Gene Therapy Presentations Flashcards

1
Q

What treatments are currently being prescribed for DMD?

A

Symptom-specific treatments, corticosteroids, dystrophin restoration therapies like exon-skipping drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What gene therapies are currently in clinical trials for DMD?

A

Two phase III trials (Pfizer and Sarepta) using AAV technologies to deliver a mini-dystrophin gene and a micro-dystrophin gene

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Who is the target audience for DMD gene therapies?

A

Ambulatory males between the ages of 4 and 7

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What gene therapies are available for SMA?

A

Spinraza (Biogen), Zolgensma (Novartis), and Evrysdi (Genentech/Roche)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How do the gene therapies for SMA work?

A

By upregulating SMN production either through splicing modifier or antisense oligonucleotide targeting SMN2 or AAV9-delivery of SMN gene

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the mechanisms behind the gene therapies designed for CF?

A

helps keep dysfunctional CFTR proteins open; recruits more CFTR proteins to the cell’s surface

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the mechanisms of gene therapies in development for Huntington disease?

A

Antisense oligonucleotides (binds to faulty HTT gene and blocks ability to produce toxic protein) and microRNAs (reduces the levels of toxic proteins causing HD)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the difference in dosing between microRNAs and antisense oligonucleotides?

A

ASOs require multiple doses whereas microRNAs theoretically only need to be delivered once

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the causative genes associated with Hemophilia A/B?

A

Factor VIII (F8) is linked to Hemophilia A and Factor IX (F9) is linked to Hemophilia B

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What gene therapy technology is being used to target hemophilia?

A

AAV5 and AAV6, targeting expression of F8 or F9 in the liver

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Who is the target audience for hemophilia gene therapy?

A

Men who are 18y/o or older

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What treatments are currently available for sickle cell disease (not gene therapies)?

A

RBC transfusions, hydroxyurea, L-glutamine, allogenic stem cell transplantation, management of symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What mechanisms do sickle cell gene therapies use?

A

Gene addition, gene editing, gene silencing, and gene correction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly